The role of calmodulin in the regulation of osteoclastogenesis

Endocrinology

Volumn 144, Issue 10, 2003, Pages 4536-4543

  Zhang, Liang ^a   Feng, Xu ^a   McDonald, Jay M ^a,b  

^a University of Alabama at Birmingham   (United States)

^b BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CALMODULIN INHIBITOR; CASPASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDOLYLMALEIMIDE; N (6 AMINOHEXYL) 5 CHLORO 1 NAPHTHALENESULFONAMIDE; PHOSPHATASE; PROTEIN C JUN; PROTEIN KINASE C INHIBITOR; SYNAPTOPHYSIN; TAMOXIFEN; TARTARIC ACID; TRIFLUOPERAZINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG INHIBITION; ENZYME ACTIVITY; IC 50; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; QUANTITATIVE ASSAY; SIGNAL TRANSDUCTION; TRABECULAR BONE;

ANIMALS; APOPTOSIS; CALMODULIN; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GLYCOPROTEINS; MICE; MICE, INBRED C57BL; OSTEOCLASTS; OSTEOPOROSIS; OSTEOPROTEGERIN; OVARIECTOMY; PROTEIN KINASE C; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; SULFONAMIDES; TAMOXIFEN; TIME FACTORS; TRIFLUOPERAZINE;

EID: 0141673456     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2003-0147     Document Type: Article

References (44)

1. Teitelbaum SL 2000 Bone resorption by osteoclasts. Science 289:1504-1508
2. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley P, Derby R, Lee R, Boyle WJ 1997 Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89:309-319
3. Tsuda E, Tsuda E, Goto M, Mochizuki S, Yano K, Kobayashi F, Morinaga T, Higashio K 1997 Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. Biochem Biophys Res Commun 234:137-142
4. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T 1998 Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical with TRANCE/RANKL. Proc Natl Acad Sci USA 95:3597-3602
5. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colobero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ 1998 Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165-176
6. Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, Morony S, Capparelli C, Li J, Elliott R, McCabe S, Wong T, Campagnuolo G, Moran E, Bogoch ER, Van G, Nguyen LT, Ohashi PS, Lacey DL, Fish E, Boyle WJ, Penninger JM 1999 Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402:304-309
7. Hsu H, Lacey D, Dunstan C, Solovyev I, Colombrero A, Timms E, Tan HL, Elliott G, Kelley MJ, Sarosi I, Wang L, Xia XZ, Ellott R, Chiu L, Black T, Scully S, Capparelli, Morony S, Shimamoto G, Bass MB, Boyle WJ 1999 Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci USA 96:3540-3545
8. Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, Morony S, Oliveira-dos-Santos AJ, Van G, Itie A, Khoo W, Wakeham A, Dunstan CR, Lacey DL, Mak TW, Boyle WJ, Penninger JM 1999 OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397:315-323
9. Pollard JW, Stanley ER 1996 Pleitotropic roles for CSF-1 in development defined by the mouse mutation osteopetrotic (op). Adv Dev Biochem 4:153-193
10. Takahashi N, Yamana H, Yoshiki S, Roodman GD, Mundy GR, Jones SJ, Boyde A, Suda T 1988 Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures. Endocrinology 122:1373-1382
11. Takahashi N, Udagawa N, Takami M, Suda T 2002 Osteoclast generation. In: Bilezikian JP, Raisz LG, Rodan GA, eds. Principles of bone biology. 2nd ed, vol 1. New York: Academic Press; 109-126
12. Katagiri T, Takahashi N 2002 Regulatory mechanisms of osteoblast and osteoclast differentiation. Oral Dis 8:147-159
13. Hoeflich KP, Ikura M 2002 Calmodulin in action: diversity in target recognition and activation mechanisms. Cell 108:739-742
14. Hall TJ 1994 A reappraisal of the effect of extracellular calcium on osteoclastic bone resorption. Biochem Biophys Res Commun 202:456-462
15. 2+ ions in freshly isolated rabbit osteoclasts. J Physiol 480:217-224
16. 2+ channel triggered by cyclic ADP-ribose. Proc Natl Acad Sci USA 92:3244-3248
17. Radding W, Williams JP, Hardy RW, McDonald JM, Whitaker CH, Turbat-Herrera EA, Blair HC 1994 Calmodulin concentrated at the osteoclast ruffled border modulates acid secretion. J Cell Physiol 160:17-28
18. Williams JP, Dong SS, Whitaker CH, Jordan SE, Blair HC 1996 Effects of cell culture time and bone matrix exposure on calmodulin content and ATP-dependent cell membrane acid transport in avian osteoclasts and macrophages. J Cell Physiol 169:411-419
19. Williams JP, Blair HC, McKenna MA, Jordan SE, McDonald JM 1996 Regulation of avian osteoclastic H+-ATPase and bone resorption by tamoxifen and calmodulin antagonists. Effects independent of steroid receptors. J Biol Chem 271:12488-12495
20. Myers DE, Collier FM, Minkin C, Wang H, Holloway WR, Malakellis M, Nicholson GC 1999 Expression of functional RANK on mature rat and human osteoclasts. FEBS Lett 463:295-300
21. McHugh KP, Hodivala-Dilke K, Zheng MH, Namba N, Lam, J, Novack D, Feng X, Ross, FP, Hynes RO, Teitelbaum SL 2000 Mice lacking β3 integrins are osteosclerotic because of dysfunctional osteoclasts. J Clin Invest 105:433-440
22. Srivastava S, Toraldo G, Weitzmann MN, Cenci S, Ross FP, Pacifici R 2001 Estrogen decreases osteoclast formation by down-regulating receptor activator of NF-κB ligand (RANKL)-induced JNK activation. J Biol Chem 276:8836-8840
23. Zhang L 1994 The role of protein kinase C in inducing Alzheimer's A68 protein expression in the culture of human neuroblastoma cells. Neurosci Lett 181:95-97
24. Sacks DB, Porter SE, Ladenson JH, McDonald JM 1991 Monoclonal antibody to calmodulin: development, characterization, and comparison with polyclonal anti-calmodulin antibodies. Anal Biochem 194:369-377
25. Zhang L, Kokkonen G, Roth SG 1995 Identification of neuronal programmed cell death in situ in the striatum of normal adult rat brain and its relationship to neuronal death during aging. Brain Res 677:177-179
26. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR 1987 Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595-610
27. Ory DS, Neugeboren BA, Mulligan RC 1996 A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc Natl Acad Sci USA 93:11400-11406
28. Feng X, Novack DV, Faccio R, Ory DS, Aya K, Boyer MI, McHugh KP, Ross FP, Teitelbaum SL 2001 A Glanzmann's mutation in β3 integrin specifically impairs osteoclast function. J Clin Invest 107:1137-1144
29. Brown OA, Sosa YE, Castro MG, Goya RG 2000 Studies on the prolactin-releasing mechanism of histones H2A and H2B. Life Sci 66:2081-2089
30. Choudhary S, Zhang W, Zhou F, Campbell GA, Chan LL, Thompson EB, Ansari NH 2002 Cellular lipid peroxidation end-products induce apoptosis in human lens epithelial cells. Free Radic Biol Med 32:360-369
31. Zimmer DB, van Eldik LJ 1989 Analysis of the calcium-modulated proteins, S100 and calmodulin, and their target proteins during C6 glioma cell differentiation. J Cell Biol 108:141-151
32. Bolander Jr FF 1985 Possible roles of calcium and calmodulin in mammary gland differentiation in vitro. J Endocrinol 104:29-34
33. Williams JP, McKenna MA, Thames 3rd AM, McDonald JM 2000 Tamoxifen inhibits phorbol ester stimulated osteoclastic bone resorption: an effect mediated by calmodulin. Biochem Cell Biol 78:715-723
34. Takami M, Takami M, Takahashi N, Udagawa N, Miyaura C, Suda K, Woo JT, Martin TJ, Nagai K, Suda T 2000 Intracellular calcium and protein kinase C mediate expression of receptor activator of nuclear factor-κB ligand and osteoprotegerin in osteoblasts. Endocrinology 141:4711-4719
35. 2+ accelerates nuclear translocation of NFκB in osteoclasts. J Biol Chem 298:8286-8293
36. Amling M, Pogoda P, Beil FT, Schilling AF, Holzmann T, Priemel M, Blicharski D, Catala-Lehnen P, Rueger JM, Ducy P, Karsenty G 2001 Central control of bone mass: brainstorming of the skeleton. Adv Exp Med Biol 496:85-94
37. Wood JG, Wallace RW, Whitaker JN, Cheung WY 1980 Immunocytochemical localization of calmodulin in regions of rodent brain. Ann NY Acad Sci 356:75-82
38. Saginario C, Sterling H, Beckers C, Kobayashi R, Solimena M, Ullu E, Vignery A 1998 MFR, a putative receptor mediating the fusion of macrophages. Mol Cell Biol 18:6213-6223
39. Saginario C, Qian HY, Vignery A 1995 Identification of an inducible surface molecule specific to fusing macrophages. Proc Natl Acad Sci USA 92:12210-12214
40. Han X, Sterling H, Chen Y, Saginario C, Brown EJ, Frazier WA, Lindberg FP, Vignery A 2000 CD47, a ligand for the macrophage fusion receptor, participates in macrophage multinucleation. J Biol Chem 275:37984-37992
41. Lydan MA, O'Day DH 1993 Calmodulin and calmodulin-binding proteins during cell fusion in Dictyostelium discoideum: developmental regulation by calcium ions. Exp Cell Res 205:134-141
42. 2+/calmodulin-dependent phosphorylation of the 100-kDa protein in chick embryonic muscle cells in culture. Dev Biol 150:223-230
43. Draznin B, Steiner C, Sherman N, Sussman K 1986 Somatostatin inhibits fusion of pituitary secretion vesicles with the plasma membranes. Biochem Biophys Res Commun 139:673-678
44. Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, Saiura A, Isobe M, Yokochi T, Inoue J, Wagner EF, Mak TW, Kodama T, Taniguchi T 2002 Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell 3:889-901